Hui-qiang Hui-Qiang Shan

Dr. Hui-qiang Hui-Qiang Shan


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

13 January 2025 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
LFLi-Long Feng
Li-Long Feng
KLKe Lu
Ke Lu
CLChong Li
Chong Li
MXMin-Zhe Xu
Min-Zhe Xu
YYYao-Wei Ye
Yao-Wei Ye
HSHui-qiang Hui-Qiang Shan
Hui-qiang Hui-Qiang Shan
Research on the link between inflammatory indicators and markers of bone metabolism is currently lacking, especially the interaction between Procollagen type 1 N-terminal propeptide (P1NP), the β-C-terminal telopeptide of type 1 collagen (β-CTX), and the fibrinogen-to-albumin ratio (FAR). This study intends to fill that knowledge gap by investigating the possible link between inflammatory indicators and bone metabolism. This observational study included 718 individuals diagnosed with osteoporotic fractures from Kunshan Hospital Affiliated to Jiangsu University between January 2017 and July 2022. After accounting for several confounders, the independent connection between FAR levels and β-CTX and P1NP was investigated via Generalized Estimating Equations (GEE). On top of that, we used a generalized additive model (GAM) to find any non-linear correlations, and a two-piecewise linear regression model to find the threshold effects in the smoothing curves that came out of it. To ensure the aforementioned result was stable, a subgroup analysis was carried out. The results showed a positive linear correlation between FAR and β-CTX [β = 1.077, 95% confidence interval (CI): 0.24 to 1.92, P = 0.012]. The study’s findings demonstrated that FAR and P1NP fit curves in an inverted U-shaped pattern, and an inflection point K = 0.0685 for FAR was detected. P1NP showed a positive correlation with FAR below the inflection point (β = 306.10, 95% CI: 47.37 to 564.83, P = 0.021), and a negative correlation with FAR beyond the inflection point (β = -117.57, 95% CI: -231.34 to -3.80, P = 0.043). The subgroup analysis revealed that women had a more significant association between FAR and β-CTX in women than in men. The results provide useful insights into the potential association between FAR and markers of bone metabolism. The study may provide a novel clinical implication by introducing FAR as a potential reference indicator for assessing bone health, offering a cost-effective and conveniently obtainable biomarker to monitor inflammation to improve bone metabolism in the treatment of osteoporosis.

31 July 2024 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
LFLi-Long Feng
Li-Long Feng
KLKe Lu
Ke Lu
CLChong Li
Chong Li
MXMin-Zhe Xu
Min-Zhe Xu
YYYao-Wei Ye
Yao-Wei Ye
HSHui-qiang Hui-Qiang Shan
Hui-qiang Hui-Qiang Shan
Background: The relationship between the levels of high-density lipoprotein (HDL) and bone mineral density (BMD) is controversial. Furthermore, the specific role of apolipoprotein A1 (APOA1), a primary HDL component, in regulating BMD remains unclear. This study aimed to elucidate the correlation between APOA1 levels and lumbar BMD in patients with osteoporotic fracture (OPF) for novel insights into potential therapeutic strategies against osteoporosis.Methods: This study included 587 OPF patients enrolled at the Kunshan Hospital, Affiliated with Jiangsu University between January 2017 and July 2022. The patient’s serum APOA1 levels were determined, followed by the assessment of lumbar BMD and C-terminal telopeptide of type I collagen (β-CTX) as outcome variables. The association of APOA1 levels with lumbar BMD and β-CTX was assessed via Generalized Estimating Equations (GEE) and spline smoothing plot analyses. A generalized additive model (GAM) helped ascertain non-linear correlations. Moreover, a subgroup analysis was also conducted to validate the result’s stability.Results: It was observed that APOA1 levels were positively correlated with lumbar BMD (β = 0.07, 95% CI: 0.02 to 0.11, p = 0.0045), indicating that increased APOA1 levels were linked with enhanced lumbar BMD. Furthermore, APOA1 levels were negatively related to β-CTX (β = −0.19, 95% CI: −0.29 to −0.09, p = 0.0003), suggesting APOA1 might reduce osteolysis. In addition, these findings were robustly supported by subgroup and threshold effect analyses.Conclusion: This study indicated that increased APOA1 levels were correlated with enhanced lumbar BMD and decreased osteolysis in OPF patients. Therefore, APOA1 may inhibit osteoclast activity to prevent further deterioration in osteoporotic patients. However, further research I warranted to validate these conclusions and elucidate the underlying physiologies.

11 March 2025 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
MCMing-Xin Chen
Ming-Xin Chen
LFLi-Long Feng
Li-Long Feng
KLKe Lu
Ke Lu
CLChong Li
Chong Li
YWYin-Lin Wei
Yin-Lin Wei
HSHui-qiang Hui-Qiang Shan
Hui-qiang Hui-Qiang Shan
Background: The number of patients with osteoporotic fractures (OPFs) is on the rise because of global aging. However, few studies have examined the connection between Geriatric Nutritional Risk Index (GNRI) and overall mortality among inpatients with OPFs. Thus, our research seeks to investigate the link between GNRI and overall mortality in inpatients with OPFs. Methods: A retrospective cohort study was investigated on 3143 Kunshan OPFs residents aged ≥ 50 years. Participants were stratified into malnutrition (GNRI ≤ 98) and no malnutrition groups (GNRI > 98). Multivariate Cox regression analyses were utilized to evaluate the connection between GNRI and overall mortality. No non-linear association was detected through smoothed curve fitting and threshold analysis. Kaplan–Meier curves were employed to compare the cumulative risk of mortality across varying nutritional conditions. Subgroup analyses were conducted to further investigate the effects of age, sex and other clinical and laboratory factors on the link between GNRI and mortality. Results: 3,143 qualified inpatients with OPFs were involved in the final evaluation. Kaplan–Meier curves revealed that the cumulative risk of mortality was markedly elevated in malnutrition group compared to no malnutrition group. In complete adjustments model, malnutrition group showed an adjusted hazard ratio (aHR) of 1.42 [95% CI 1.05, 1.90; P-value = 0.021]. Furthermore, subgroup analyses revealed that no substantial interactions were detected among all variables. (P-interaction > 0.05). Conclusions: Reduced GNRI scores are linked to higher mortality in inpatients with OPFs. The GNRI potentially serve as a predictor for overall mortality risk in this population.

9 October 2026 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
MCMing-Xin Chen
Ming-Xin Chen
LFLi-Long Feng
Li-Long Feng
XHXiang-Yu Huang
Xiang-Yu Huang
CWCheng Wang
Cheng Wang
KLKe Lu
Ke Lu
HSHui-qiang Hui-Qiang Shan
Hui-qiang Hui-Qiang Shan
Background: We assessed the association between the non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio (NHHR) and prevalent hyperuricemia (HUA) in adults hospitalized with fractures. We also examined overlap with other lipid measures and exploratory incremental discrimination. Methods: This retrospective cross-sectional study included 2699 adults aged ≥ 50 years with observed serum uric acid, total cholesterol, and high-density lipoprotein cholesterol (HDL-C). Each patient contributed one index hospitalization, defined as the first eligible hospitalization during the study period. Fasting biochemical measurements were obtained within the first 24 hours after admission; later inpatient values were excluded. HUA was defined as serum uric acid ≥ 416 μmol/L in men or ≥357 μmol/L in women. We estimated prevalence odds ratios (ORs) and modified-Poisson prevalence ratios (PRs) as complementary measures of association across 20 multiple-imputation (MI) datasets. Models used clinically informed covariates and flexible estimated glomerular filtration rate (eGFR) adjustment. Complete-case, selection-weighted, and alternative-threshold analyses assessed sensitivity. Results: HUA was present in 418 patients (15.5%). Per one standard deviation (SD) higher NHHR, the MI-pooled OR was 1.188 (95% confidence interval [CI] 1.061–1.330; p = 0.003). The corresponding PR was 1.129 (95% CI 1.045–1.220; p = 0.002). Selection-weighted estimates were similar (OR 1.191; PR 1.131), although lipid missingness and limited positivity constrain interpretation. The complete-case OR was 1.130 (95% CI 0.999–1.277). Nonlinear evidence was unstable after trimming extreme NHHR values. In a joint model including triglycerides and low-density lipoprotein cholesterol, the NHHR OR was 1.046 (95% CI 0.876–1.248). Adding NHHR changed cross-validated area under the receiver operating characteristic curve (AUC) from 0.777 to 0.780 (ΔAUC 0.0026; conditional 95% interval −0.0016–0.0070). Conclusions: NHHR showed a modest association with prevalent HUA in this selected fracture-hospitalized population. Interpretation is tempered by missing-data assumptions, overlapping lipid information, and limited incremental discrimination. Fasting first-24-hour sampling cannot fully distinguish chronic metabolic status from acute hospitalization physiology; no validated prediction role or clinical NHHR cutoff is established. Clinical trial number: Not applicable.